ArticleFrontiers in oncology2025
Supervised contrastive loss helps uncover more robust features for photoacoustic prostate cancer identification.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Photoacoustic spectral analysis has been demonstrated to be efficacious in the diagnosis of prostate cancer (PCa). With the incorporation of deep learning, its discrimination accuracy is progressively enhancing. Nevertheless, individual heterogeneity persists as a significant factor that impacts discrimination performance. Objective: Extracting more reliable features from intricate biological tissue and augmenting discrimination accuracy of the prostate cancer. Methods: Supervised contrastive learning is introduced to explore its performance in photoacoustic spectral feature extraction. Three distinct models, namely the CNN-based model, the supervised contrastive (SC) model, and the supervised contrastive loss adjust (SCL-adjust) model, have been compared, along with traditional feature extraction and machine learning-based methods. Results: The outcomes have indicated that the SCL-adjust model exhibits the optimal performance, its accuracy rate has increased by more than 10% compared with the traditional method. Besides, the features extracted from this model are more resilient, regardless of the presence of uniform or Gaussian noise and model transfer. Compared with CNN model, the transfer performance of the proposed model has improved by approximately 5%. Conclusions: Supervised contrast learning is integrated into photoacoustic spectrum analysis and its effectiveness is verified. A comprehensive analysis is conducted on the performance improvement of the proposed SCL-adjust model in photoacoustic prostate cancer diagnosis, its resistance to noise, and its adaptability to the data heterogeneity of different systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.